SCHEMBL22924100

SCHEMBL22924100

CCc1c(C)cc(F)c2[nH]nc(F)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22328041 0.84 KDR (0.34) —
SCHEMBL25667661 0.79 ADORA2A (0.33) —
SCHEMBL25696139 0.75 — —
SCHEMBL22328048 0.73 — —
SCHEMBL22328047 0.71 NOS3 (0.33) —
SCHEMBL25702366 0.70 METAP2 (0.34) —
SCHEMBL29297677 0.66 HTR1D (0.45) —
SCHEMBL25667667 0.66 KDR (0.37) —
SCHEMBL15215000 0.64 RAPGEF4 (0.32) —
SCHEMBL14846045 0.62 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024501-A1 COVALENT INHIBITORS OF KRAS ARAXES PHARMA LLC 2021-01-28 — — US disclosed
Send feedback